From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

HIGH-DOSE ASPIRIN MAY SLOW CAROTID ATHEROSCLEROSIS.

Some data suggest that long-term aspirin therapy can slow the progression of occlusive peripheral arterial disease, but it is unclear what dosage is required to achieve this benefit. These investigators studied 27 patients from a larger trial that compared low-dose with high-dose aspirin given after coronary angioplasty. These 27 patients had a total of 104 carotid atheromas and were followed with serial ultrasound studies.

After 1 year, the average plaque size had not changed in the 14 patients taking 900 mg of aspirin daily, but had increased by about one-third in the 13 patients taking the 50-mg dose. Ultrasonography documented the disappearance of 9 lesions in the high-dose group, but none in the low-dose group.

Comment: Although these data come from a small number of patients, they suggest that 50 mg of aspirin daily is not sufficient to slow progression of carotid atherosclerosis and that 900 mg may have beneficial effects. Because of the gastrointestinal side effects of high-dose aspirin, future studies should determine whether doses less than 900 mg would be equally effective.

— THL

Published in Journal Watch General Medicine June 29, 1993

Citation(s):

Ranke C et al. Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation 1993 Jun 87 1873-1879.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1993. Massachusetts Medical Society. All rights reserved.